NCT04261387 2022-07-27
LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients
Lutris Pharma Ltd.
Phase 1/2 Completed
Clinical Trials
4 trialsNCT02534129 2017-10-06
Topical Use of Difinsa53â„¢ to Prevent Radiation Dermatitis
ProTechSure Scientific, Inc.
Phase 1/2 Terminated
NCT01513278 2013-07-15
Study of APN201 (Liposomal Recombinant Human Cu/Zn-Superoxide Dismutase) for the Prevention of Radiation-induced Dermatitis in Women With Breast Cancer
Apeiron Biologics
Phase 1/2 Completed
NCT01544504 2012-05-28
Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy
ProCertus BioPharm, Inc
Phase 1/2 Withdrawn